News

Incyte today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in ...
Medically reviewed by Katlein Franca, MD Skin cancer is a type of cancer that begins in the skin cells, and its appearance can vary widely depending on the type of cancer. Understanding the variations ...